{"data":[{"accessionNo":"0001517022-26-000044","issuerCik":"0001517022","issuerName":"Akebia Therapeutics, Inc.","ticker":"AKBA","personName":"Ostrowski Erik","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC","unitsToSell":56019,"aggregateMarketValue":62220,"unitsOutstanding":268258243,"approxSaleDate":"2026-06-29","exchange":"Nasdaq","filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/akba"},{"accessionNo":"0001517022-26-000013","issuerCik":"0001517022","issuerName":"Akebia Therapeutics, Inc.","ticker":"AKBA","personName":"Ostrowski Erik","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC","unitsToSell":34951,"aggregateMarketValue":48739,"unitsOutstanding":265365993,"approxSaleDate":"2026-02-02","exchange":"Nasdaq","filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/akba"},{"accessionNo":"0001517022-26-000012","issuerCik":"0001517022","issuerName":"Akebia Therapeutics, Inc.","ticker":"AKBA","personName":"Grund Nicholas","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC","unitsToSell":84829,"aggregateMarketValue":118294,"unitsOutstanding":265365993,"approxSaleDate":"2026-02-02","exchange":"Nasdaq","filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/akba"},{"accessionNo":"0001517022-26-000011","issuerCik":"0001517022","issuerName":"Akebia Therapeutics, Inc.","ticker":"AKBA","personName":"Burke Steven Keith","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC","unitsToSell":67658,"aggregateMarketValue":94349,"unitsOutstanding":265365993,"approxSaleDate":"2026-02-02","exchange":"Nasdaq","filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/akba"},{"accessionNo":"0001517022-26-000010","issuerCik":"0001517022","issuerName":"Akebia Therapeutics, Inc.","ticker":"AKBA","personName":"Butler John P.","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC","unitsToSell":341305,"aggregateMarketValue":475950,"unitsOutstanding":265365993,"approxSaleDate":"2026-02-02","exchange":"Nasdaq","filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/akba"},{"accessionNo":"0001517022-26-000009","issuerCik":"0001517022","issuerName":"Akebia Therapeutics, Inc.","ticker":"AKBA","personName":"Rucci Carolyn M.","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC","unitsToSell":69772,"aggregateMarketValue":97297,"unitsOutstanding":265365993,"approxSaleDate":"2026-02-02","exchange":"Nasdaq","filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/akba"}],"updatedAt":"2026-11-04T05:07:12.102Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/akba","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}